LIPO News and Press, Lipella Pharmaceuticals Inc. From 04/08/25

PITTSBURGH, April 08, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced the completion of enrollm...

PITTSBURGH, March 31, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today ann...

Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares) (CDLR) is expected to report $0.34 for Q4 2024 China Mengniu Dairy Company Limited ADR (CIADY) is expected to report for Q4 2024 Atossa Therapeutics Inc. (ATOS) is expected to report $-0.06 for Q4 2024 ...

Gritstone bio Inc. (GRTS) is expected to report for Q4 2024 OneConnect Financial Technology Co. Ltd. American Depositary Shares each representing thirty (OCFT) is expected to report for quarter end 2024-12-31 2seventy bio Inc. (TSVT) is expected to report $-0.2 for Q4 2024 CorMedix In...

Algoma Steel Group Inc. (ASTL) is expected to report $0.06 for Q3 2025 E.W. Scripps Company (The) (SSP) is expected to report for Q4 2024 TransAct Technologies Incorporated (TACT) is expected to report $-0.1 for Q4 2024 Kindly MD, Inc. (KDLY) is expected to report for Q4 2024 Talo...

New York, NY, March 07, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC , a full-service investment banking firm, is pleased to announce a series of strategic transactions completed in February 2025, reinforcing its position as a trusted financial partner for companies across div...

New York, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of a $3,788,000 private placement for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO). Spartan Capital Securities, LLC acted as the sol...

Veritec, Inc. (VRTC) is expected to report for quarter end 2024-12-31 Nayax Ltd. (NYAX) is expected to report $0.04 for Q4 2024 CrowdStrike Holdings Inc. (CRWD) is expected to report $0.01 for Q4 2025 Schaeffler AG Bearer Preference Shares (SCFLF) is expected to report for quarter end...

ASM International NV New York Shares (ASMIY) is expected to report $3.98 for Q4 2024 Sezzle Inc. (SEZL) is expected to report $3.12 for Q4 2024 Fresenius SE & Co. KGaA ADR (FSNUY) is expected to report for Q4 2024 OraSure Technologies Inc. (OSUR) is expected to report $-0.06 for Q...

2025-02-11 12:10:00 ET A biotech company is turning heads so far during Tuesday’s session after it shared topline analysis of its Phase 2a dose-ranging trial of LP-310, a liposomal-tacrolimus oral rinse formulation of LP-10 being developed to treat oral lichen planus (OLP), according...